Plexus Corp

Aktienanalyse zu Plexus Corp (PLXS)

$240.870

-4.480 (-1.86%)Zum Schluss

Loading chart…
High
246.830
Open
246.830
VWAP
242.80
Vol
165.97K
Mkt Cap
2.80B
Low
240.690
Amount
40.30M
EV/EBITDA, TTM
19.03

Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors.

AI analysis of Plexus Corp (PLXS)

buy

Plexus Corp is a good buy right now due to its strong recent earnings performance, with a Q3 2026 EPS of $2.32, exceeding expectations by $0.18, and a revenue of $1.31 billion, reflecting a 29.7% year-over-year increase. Additionally, the forward P/E ratio of 24.10 suggests that the stock is reasonably valued compared to its growth prospects. However, a notable risk is the recent insider selling, which has increased by 1088.24%, indicating potential concerns among insiders about the company's future performance.

Analyst Ratings (8)

-13.37% downside
Hold
1 Buy
6 Hold
1 Sell
Current: 240.87
Tief
200.00
Durchschnitt
208.67
Hoch
220.00

Sidoti

2026-07-31

Kursziel

$308

Buy

Stifel

2026-06-22

Kursziel

$330

Buy

Needham

2026-06-01

Kursziel

$310

Buy

Stifel

2026-05-01

Kursziel

$280

Buy

Needham

2026-05-01

Kursziel

$285

Buy

Bewertungskennzahlen

The current forward P/E ratio for Plexus Corp (PLXS) is 24.10, compared to its 5-year average forward P/E of 19.06.

Forward P/E

Overvalued
5Y Average P/E
19.06
Current P/E
24.10
Überbewertet
22.47
Unterbewertet
15.65

Forward EV/EBITDA

Strongly Overvalued
5Y Average EV/EBITDA
11.92
Current EV/EBITDA
19.03
Überbewertet
15.26
Unterbewertet
8.59

Forward P/S

Overvalued
5Y Average P/S
0.79
Current P/S
1.15
Überbewertet
1.01
Unterbewertet
0.58

Alphio AI Price Scenarios for PLXS

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PLXS

$137.73

Szenariopreis

B

Base

Base · 50%PLXS

$124.84

Szenariopreis

B

Bear

Bear · 25%PLXS

$96.73

Szenariopreis

Whales holding PLXS

S

Silvercrest Asset Management Group LLC

+ HoldingPLXS

-2.01%

3M Return

G

GHP Investment Advisors, Inc.

+ HoldingPLXS

-2.87%

3M Return

C

Cartenna Capital LP

+ HoldingPLXS

-3.35%

3M Return

E

Emerald Advisers, LLC

+ HoldingPLXS

-6.34%

3M Return

Event-Zeitleiste

2026-08-11 (ET)

08:00:00

Littelfuse Appoints Todd Kelsey to Board of Directors

2026-07-29 (ET)

17:00:00

Plexus Reports Q3 Revenue of $1.3B, Exceeding Expectations

17:00:00

Company Forecasts Q4 Revenue of $1.33B to $1.38B

17:00:00

Plexus Anticipates Over 20% Revenue Growth for Fiscal 2026

2026-04-29 (ET)

16:50:00

Company Sees Q3 Revenue of $1.2B-$1.25B

News

PLXS FAQ — answered by Alphio AI

Plexus Corp. is engaged in providing design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services. The Company's design and development capabilities include product strategy, product development, design for excellence (DFX), and test engineering. Its new product introduction capabilities include DFX, transition management, test engineering, supply chain management, and rapid prototype. Its manufacturing capabilities include end-to-end manufacturing, integrated test and inspection, fulfillment and logistics. Its supply chain capabilities include early engagement and early engagement. Its sustaining service capabilities include distribution management, product life cycle extension, aftermarket services, repair and refurbishment. It serves the aerospace, defense, security, space, advanced surgical systems, medical robotics, life sciences, diagnostics, medical devices and equipment sectors. It operates in the Technology sector (PRINTED CIRCUIT BOARDS industry).

Plexus Corp is a good buy right now due to its strong recent earnings performance, with a Q3 2026 EPS of $2.32, exceeding expectations by $0.18, and a revenue of $1.31 billion, reflecting a 29.7% year-over-year increase. Additionally, the forward P/E ratio of 24.10 suggests that the stock is reasonably valued compared to its growth prospects. However, a notable risk is the recent insider selling, which has increased by 1088.24%, indicating potential concerns among insiders about the company's future performance.

8 analysts cover PLXS: 1 rate it Buy, 6 Hold and 1 Sell. The average price target is 208.67.

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Kostenlos starten